Eedris Abudulkareem’s Kidney Transplant Surgery Date Moved’ – Manager Gives Update

Eedris Abdulkareem 1 1

Mike Pam, the Manager of veteran Nigerian singer, Eedris Abdulkareem has given update on his health challenges.

Nigeria Jaga Jaga Crooner was down with kidney failure and would be needing a transparent with his lovely wife as the donor.

Keeping Nigerians updated, Mike Pam took to his social media page to appreciate all who had in different ways supported the ailing Rapper.

He wrote: “OFFICIAL UPDATE ON EEDRIS ABDULKAREEM’S HEALTH CHALLENGES

In furtherance to our earlier report on the health challenges of the Nigerian Hip Hop Czar Eedris Abdulkareem, and our promise and commitment to keep you updated as we move along with the process, the management of Lakreem Entertainment on behalf of the Abdulkareem family, hereby reports that the scheduled kidney transplant surgery which was tentatively slated for the July 27, have been moved forward by the doctors.

Eedris who is still in high spirits and making a few cameo appearances as an artiste, is religiously undergoing the prescribed 3 times weekly dialysis, while abiding by all the doctor’s directives and required lifestyle changes.

As we await the substantive surgery date, which may take place any moment from now as all arrangements have been made, we wish to also use this opportunity to thank and appreciate everyone for your massive outpouring of prayers, love, care, affection and support.

The show of love and support from both home and abroad have been quite amazing and truly overwhelming. Most importantly, it means the world to the ailing Eedris, as it undoubtedly represents the required tonic that is most helpful in propelling him to fight and win this battle.

We will be forever grateful!

In conclusion, we humbly implore that the prayers and solidarity continues until we cross this crooked bridge of obstruction with solid faith in God and verifiable medical science.

May God continue to bless and abide with us all.

Myke Pam

For: Lakreem Entertainment Inc.”

Be the first to comment

Leave a Reply

Your email address will not be published.